altmeds Briefs CBD Products & CBD Business News

Elixinol Buys 25% Stake In Pet Releaf CBD Brand.

Elixinol has purchased a 25% stake in Altmeds, the manufacturer of hemp-derived CBD pet health brand Pet Releaf. The terms of the deal were not disclosed. Denver-based Altmeds already gets its CBD from Elixinol, a Colorado producer of hemp-derived CBD extract. The Altmeds investment allows Elixinol to gain a foothold in the growing CBD pet-products […]

Elixinol buys 25% stake in Pet Releaf CBD brand is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Laura Drotleff